AstraZeneca refutes reports linking its COVID-19 vaccine with recent deaths in Europe from blood clots; Anthony Fauci, MD, cautions against lifting US restrictions too soon amid case spikes in Europe; the White House is set to reveal a $1.5 billion public relations campaign to boost vaccine confidence and uptake nationwide.
Yesterday, AstraZeneca (AZ) refuted reports linking its COVID-19 vaccine with recent deaths in Europe from blood clots, as the company said in a statement that there is no scientific evidence on the association, although more countries continue to temporarily halt use of the vaccine. Reported by The Washington Post, the Dutch government had announced yesterday that it was suspending use of the AZ shot for the next 2 weeks as it investigates its safety, joining Ireland and Italy’s northern Piedmont region. So far, the AZ vaccine has been administered to 17 million people, with 15 cases of deep vein thrombosis and 22 pulmonary embolisms, which were noted by the company to be lower than expected.
Amid recent spikes in cases of COVID-19 throughout Europe that coincided with the relaxation of safety measures, America’s top infectious disease expert, Anthony Fauci, MD, cautioned against lifting US restrictions too soon. CNBC reports that as case trends in the United States continue to decline, those in Italy, Germany, Poland, and Hungary have spiked significantly, with the Czech Republic and Slovakia exhibiting the highest death rates worldwide. Notably, European countries are said to be struggling with their vaccine rollout, whereas the United States has administered 107 million vaccines and recorded a decline of 11% in new virus infections in the last week.
According to STAT, the White House is set to reveal an expansive $1.5 billion public relations campaign that will serve to boost vaccine confidence and uptake nationwide. Relayed through television, radio, and digital advertising, the campaign will focus on addressing skepticism of vaccines’ safety or effectiveness, as well as educating eager Americans who want the vaccine on where, when, and how they can receive it. Specifically, the campaign is said to target 3 groups in which access, apathy, or outright skepticism may pose a barrier to vaccinations, including young people, people of color, and conservatives.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More